Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-2.89	73.82	76.02
Graham Fair Price	13.24	5.93	5.24
PEG	-98.90	2.03	183.45
Price/Book	-2.47	3.07	3.15
Price/Cash Flow	17.81	105.00	89.13
Prices/Earnings	-26.79	69.81	95.35
Price/Sales	-4.32	29.13	30.44
Price/FCF	17.81	105.00	89.13
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-11.21	0.21	0.24
Operating Margin	0.57	0.17	0.17
ROA	32.95	< 0.005	< 0.005
ROE	< 0.005	0.01	33.22
ROIC	< 0.005	< 0.005	5.58
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	< 0.005	-17.87
Dividends QOQ	< 0.005	< 0.005	38.23
EBIT QOQ	-0.12	< 0.005	-94.50
EPS QOQ	< 0.005	0.34	6525.56
FCF QOQ	0.15	-0.19	23.86
Revenue QOQ	< 0.005	< 0.005	-88.60
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	-64.85	-100.00
Days Sales Outstanding (DSO)	49.83	51.22	2.78
Inventory Turnover	0.00	-1.39	-100.00
Debt/Capitalization	0.61	0.60	-2.23
Quick Ratio	0.32	0.34	6.78
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	12.15	11.92	-1.89
Cash	0.14	0.13	-8.03
Capex	-0.24	-0.17	26.72
Free Cash Flow	0.43	0.35	-18.77
Revenue	1.26	1.26	< 0.005
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.31	0.33	7.10
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	24.41	24.31	-0.41
Naive Interpretation	Member

06 - Financial Health · Bad

Rating